Clinical Trial Update: A Study to Assess the Safety, Efficacy, and Pharmacokinetics of Multiple Doses of ION224 [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating multiple doses of ION224 for safety, efficacy, and pharmacokinetics in nonalcoholic steatohepatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis

Drugs mentioned

• ION224

Snippet

Sponsor: Ionis Pharmaceuticals, Inc. | Conditions: Steatohepatitis, Nonalcoholic | Phase 2 | Status: COMPLETED